Harvard Business School has announced the launch of a new dual-degree MBA / MS in Biotechnology.
According to the school, the new joint program will explore the intersection between business and the life sciences. While the MBA courses will be delivered at the Harvard Business School, the life sciences curriculum will take place through Harvard’s Department of Stem Cell and Regenerative Biology, a joint department between Harvard’s Faculty of Arts and Sciences and Harvard Medical School.
The new program will be two years long. In the summer between the first and second years, students will be able to pursue an internship in biotech or the life sciences space.
The Biotech MBA / MS program is aimed at candidates with either an undergraduate degree in life sciences or medicine and / or work experience in the life sciences / biotech field. The school will also consider those without STEM-oriented undergraduate degrees, providing these candidates have life sciences experience.
The first intake of the new dual-degree MBA will begin in the fall of 2020.
For more information or to apply, please see the Harvard news release announcing the launch of the MBA / MS Biotech program.
